To elucidate the molecular mechanism of TUBB4A/MYH9-mediated tumor progression, we assessed, with DU145 cells, the role of TUBB4A/MYH9 on the GSK3β/β-catenin signaling pathway by immunoblotting analysis. This evidence concerns the gene TUBB4A and neoplasm.